Nuo Therapeutics, Inc. (AURX) Gross profit 2017–2025
Nuo Therapeutics, Inc. (AURX) annual gross profit history from SEC filings — each fiscal year as reported.
$2.2MFY2025 · since FY2017: -$369,997 → $2.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $2.2M | +108.8% |
| FY2024 | $1.1M | +120.2% |
| FY2023 | $482,433 | +418.5% |
| FY2022 | $93,036 | — |
| FY2021 | $0 | — |
| FY2020 | $0 | -100.0% |
| FY2019 | $31,563 | -97.4% |
| FY2018 | $1.2M | +426.4% |
| FY2017 | -$369,997 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More AURX financial trends
AURX RevenueAURX Net incomeAURX Net marginAURX Gross marginAURX Operating incomeAURX Operating marginAURX Operating cash flowAURX Free cash flowAURX Capital expendituresAURX Return on equityAURX Stock buybacksAURX Dividends paidAURX Total assetsAURX Total liabilitiesAURX Shareholders’ equityAURX overview →